Association Between Inflammatory Biomarkers and Cognitive Dysfunction Analyzed by MRI in Diabetes Patients

References

• Giraud-Billoud M, Fader CM, Agüero R, Ezquer F, Ezquer M. Diabetic nephropathy, autophagy and proximal tubule protein endocytic transport: a potentially harmful relationship. Biocell. 2018;42:35–40. doi:10.32604/biocell.2018.07010
   Google Scholar
• Dejong R. The nervous system complications of diabetes mellitus, with special reference to cerebrovascular changes. J Nerv Ment Dis. 1950;111(3):181–206. doi:10.1097/00005053-195011130-00001
   Google Scholar
• Cukierman T, Gerstein H, Williamson J. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460–2469. doi:10.1007/s00125-005-0023-4
   PubMed Web of Science ®Google Scholar
• Munoz EM. Microglia-precursor cell interactions in health and in pathology. Biocell. 2018;42(2):41–45. doi:10.32604/biocell.2018.07011
   Web of Science ®Google Scholar
• Nunley KA, Rosano C, Ryan CM, et al. Clinically relevant cognitive impairment in middle-aged adults with childhood-onset type 1 diabetes. Diabetes Care. 2015;38(9):1768–1776. doi:10.2337/dc15-0041
   PubMed Web of Science ®Google Scholar
• Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044–1080. doi:10.1080/13803390490514875
   PubMed Web of Science ®Google Scholar
• Manschot SM, Brands AMA, Van der Grond J, et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes. 2006;55(4):1106–1113. doi:10.2337/diabetes.55.04.06.db05-1323
   PubMed Web of Science ®Google Scholar
• Robinson JG, Watson KE. Identifying patients for nonstatin therapy. Rev Cardiovasc Med. 2018;19(S1):S1–S8.
   PubMedGoogle Scholar
• Li W, Huang E, Gao SJ. Type 1 diabetes mellitus and cognitive impairments: a systematic review. Alzheimers Dis. 2017;57(1):29–36. doi:10.3233/JAD-161250
   PubMed Web of Science ®Google Scholar
• Mansur RB, Lee Y, Zhou AJ, et al. Determinants of cognitive function in individuals with type 2 diabetes mellitus: a meta-analysis. Ann Clin Psychiatry. 2018;30(1):38–50.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhang J, Fan Y, et al. Abnormal levels of brain metabolites may mediate cognitive impairment instroke-free patients with cerebrovascular risk factors. Age Ageing. 2014;43(5):681–686. doi:10.1093/ageing/afu027
   PubMedGoogle Scholar
• Bolo NR, Musen G, Simonson DC, et al. Functional connectivity of insula, basal ganglia, and prefrontal executive control networks during hypoglycemia in type 1 diabetes. J Neurosci. 2015;35(31):11012–11023. doi:10.1523/JNEUROSCI.0319-15.2015
   PubMed Web of Science ®Google Scholar
• Leslie RD, Palmer J, Schloot NC, Lernmark A. Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment. Diabetologia. 2016;59:13–20. doi:10.1007/s00125-015-3789-z
   PubMed Web of Science ®Google Scholar
• Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66(2):241–255. doi:10.2337/db16-0806
   PubMed Web of Science ®Google Scholar
• Liu L, Chan C. IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for alzheimer’s disease. Neurobiol Aging. 2014;35:309–321. doi:10.1016/j.neurobiolaging.2013.08.016
   PubMedGoogle Scholar
• Czeh B, Lucassen PJ. What causes the hippocampal volume decrease in depression? Are neurogenesis, glial changes and apoptosis implicated? Eur Arch Psychiatry Clin Neurosci. 2007;257(5):250–260. doi:10.1007/s00406-007-0728-0
   PubMedGoogle Scholar
• WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. WHO. 2006:50.
   Google Scholar
• Cameron FJ, Scratch SE, Nadebaum C, et al. Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a Prospective Cohort Study of Children. Diabetes Care. 2014;37(6):1554–1562. doi:10.2337/dc13-1904
   PubMed Web of Science ®Google Scholar
• Zonis S, Ljubimov VA, Mahgerefteh M, et al. p21 Cip restrains hippocampal neurogenesis and protects neuronal progenitors from apoptosis during acute systemic inflammation. Hippocampus. 2013;23(12):1383–1394. doi:10.1002/hipo.22192
   PubMedGoogle Scholar
• van Duinkerken E, Schoonheim MM, Sanz-Arigita EJ, et al. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes. 2012;61(7):1814–1821. doi:10.2337/db11-1358
   PubMed Web of Science ®Google Scholar
• Mauras N, Mazaika P, Buckingham B, et al. Longitudinal assessment of neuroanatomical and cognitive differences in young children with type 1 diabetes: association with hyperglycemia. Diabetes. 2015;64(5):1770–1779. doi:10.2337/db14-1445
   PubMedGoogle Scholar
• Zhou J, Li H, Ran X, et al. Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med Sci Monit. 2011;17(1):CR9–CR13. doi:10.12659/MSM.881318
   PubMedGoogle Scholar
• Zou J, Crews FT. Inflammasome–IL-1β signaling mediates ethanol inhibition of hippocampal neurogenesis. Front Neurosci. 2012;30(6):77.
   Google Scholar
• Rizzo MR, Barbieri M, Marfella R, et al. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care. 2012;35(10):2076–2082. doi:10.2337/dc12-0199
   PubMed Web of Science ®Google Scholar